High‐dose vs low‐dose regimens of thrombolytic agentsMajor bleeding · patients with < 42 days' limb ischaemiaa1 finding from 1 reviewInfusion techniques for peripheral arterial thrombolysis 2021 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 302 participantsVery low
ASA + high‐dose LMWH vs ASA + low‐dose LMWH or UFHBleeding ‐ major/excessive · people with antiphospholipid antibodies and no history of thrombosis1 finding from 1 reviewAntiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid… 2018 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 120 participantsGRADE not reported